- -

Nortriptyline hydrochloride skin absorption: development of a transdermal patch

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Nortriptyline hydrochloride skin absorption: development of a transdermal patch

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Melero, Ana es_ES
dc.contributor.author Garrigues, T.M. es_ES
dc.contributor.author Almudéver-Folch, Patricia es_ES
dc.contributor.author Martín Villodre, A. es_ES
dc.contributor.author Lehr, C.M. es_ES
dc.contributor.author Schäfer, U. es_ES
dc.date.accessioned 2024-02-07T19:02:13Z
dc.date.available 2024-02-07T19:02:13Z
dc.date.issued 2008-06 es_ES
dc.identifier.issn 0939-6411 es_ES
dc.identifier.uri http://hdl.handle.net/10251/202397
dc.description.abstract [EN] The influence of propylen glycol (PG), ethanol, and oleic acid (OA) on nortriptyline hydrochloride (NTH) penetration through human epidermis was studied in vitro at two different pH values (5.5 and 7.4). The influence of lactic acid and polysorbate 80 was studied for a pH of 5.5. Permeation studies through Heat Separated Epidermis, as well as the enhancing effect of the different vehicles, showed a pH dependency. A pH value of 5.5 in the donor solution decreases significantly the permeability coefficient (Kp) with respect to a pH value of 7.4 (0.011+/-0.004 x 10(-6) versus 0.36+/-0.04 x 10(-6)cm/s). The vehicles showed an increasing enhancement effect in the order: polysorbate 80>ethanol/PG/OA>PG>ethanol>ethanol/lactic acid>lactic acid at pH 5.5 while they reduced the permeation of NTH at pH 7.4. Considering the results obtained at pH 5.5, the maximum enhancement ratios were found for polysorbate 80 and the combination ethanol/PG/OA (10.72 and 3.90). Both vehicles were selected for designing a NTH transdermal delivery system (NTH-TDS) using (hydroxypropyl)methyl-cellulose as polymer. The NTH-TDS based on the combination of ethanol/PG/OA showed an enhancement ratio with respect to control of 2.09 and the addition of polysorbate 80 to the matrix, of 5.82. es_ES
dc.description.sponsorship The Galenos Network-Marie Curie-Fellowship agreement in the framework of the EU Project "Towards a European Ph.D. in Advanced Drug Delivery" MESTCT-2004-504992. Funds were received from the Generalitat Valenciana (GV06-163). The authors thank Dr. Javier Pascual (Hospital 9 Octubre, Valencia) and Dr. Karl-Heinz Kostka (Caritas Krankenhaus, Lebach) for providing the human skin samples. es_ES
dc.language Inglés es_ES
dc.publisher Elsevier es_ES
dc.relation.ispartof European Journal of Pharmaceutics and Biopharmaceutics es_ES
dc.rights Reconocimiento - No comercial - Sin obra derivada (by-nc-nd) es_ES
dc.subject Percutaneous absorption es_ES
dc.subject Chemical enhancers es_ES
dc.subject Nortriptyline es_ES
dc.subject TDS es_ES
dc.subject Skin es_ES
dc.subject.classification MICROBIOLOGIA es_ES
dc.title Nortriptyline hydrochloride skin absorption: development of a transdermal patch es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1016/j.ejpb.2007.11.012 es_ES
dc.relation.projectID info:eu-repo/grantAgreement/EC//MEST-CT-2004-504992//Towards a European Ph.D. in Advanced Drug Delivery (GALENOS Euro-PhD)/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/GVA//GV%2F06%2F163/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural - Escola Tècnica Superior d'Enginyeria Agronòmica i del Medi Natural es_ES
dc.description.bibliographicCitation Melero, A.; Garrigues, T.; Almudéver-Folch, P.; Martín Villodre, A.; Lehr, C.; Schäfer, U. (2008). Nortriptyline hydrochloride skin absorption: development of a transdermal patch. European Journal of Pharmaceutics and Biopharmaceutics. 69(2):588-596. https://doi.org/10.1016/j.ejpb.2007.11.012 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https:/doi.org/10.1016/j.ejpb.2007.11.012 es_ES
dc.description.upvformatpinicio 588 es_ES
dc.description.upvformatpfin 596 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 69 es_ES
dc.description.issue 2 es_ES
dc.identifier.pmid 18191555 es_ES
dc.relation.pasarela S\427855 es_ES
dc.contributor.funder European Commission es_ES
dc.contributor.funder Generalitat Valenciana es_ES
dc.subject.ods 03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem